Publication: Distribution of tumor-infiltrating immune cells in glioblastoma
| dc.contributor.author | Orrego Puelles, Enrique, | |
| dc.contributor.author | Castaneda, Carlos A | |
| dc.contributor.author | Castillo, Miluska | |
| dc.contributor.author | Bernabe, LA | |
| dc.contributor.author | Casavilca, Sandro | |
| dc.contributor.author | Chakravarti, A | |
| dc.contributor.author | Meng, W | |
| dc.contributor.author | Garcia-Corrochano, Pamela | |
| dc.contributor.author | Villa-Robles, MR | |
| dc.contributor.author | Zevallos, R | |
| dc.contributor.author | Mejia, O | |
| dc.contributor.author | Deza, Pedro | |
| dc.contributor.author | Belmar-Lopez | |
| dc.contributor.author | Ojeda, CL | |
| dc.date.accessioned | 2024-07-01T16:29:07Z | |
| dc.date.available | 2024-07-01T16:29:07Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Aim: Evaluation of features related to infiltrating immune cell level in glioblastoma. Methods: Tumor-infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysis. Results: CD68 (9.1%), CD163 (2.2%), CD3 (1.6%) and CD8 (1.6%) had the highest density. Higher CD4+ was associated with unmethylated MGMT (p = 0.016). Higher CD8+ was associated with larger tumoral size (p = 0.027). Higher CD163+ was associated with higher age (p = 0.044) and recursive partitioning analysis = 4. Women (p < 0.05), total resection (p < 0.05), MGMT-methylation (p < 0.001), radiotherapy (p < 0.001), chemotherapy (p < 0.001) and lower CD4+ (p < 0.05) were associated with longer overall survival. Conclusion: Macrophages are more frequent than TILs. Some subsets are associated with clinical features. | |
| dc.format | application/pdf | |
| dc.identifier.doi | 10.2217/cns-2017-0037 | |
| dc.identifier.journal | CNS Oncol | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14703/148 | |
| dc.language.iso | eng | |
| dc.publisher | Future Medicine Ltd. | |
| dc.publisher.country | UK | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | MGMT | |
| dc.subject | biomarker | |
| dc.subject | glioblastoma | |
| dc.subject | macrophages | |
| dc.subject | overall survival | |
| dc.subject | prognosis | |
| dc.subject | tumor-infiltrating lymphocytes | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.21 | |
| dc.title | Distribution of tumor-infiltrating immune cells in glioblastoma | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1